Evidence map›Paper›PMID 39462744›Full record

ArticleNeurobiology of disease2024

Corrigendum to "TDP-43-M323K causes abnormal brain development and progressive cognitive and motor deficits associated with mislocalised and increased levels of TDP-43" [Neurobiology of disease Volume 193, April 2024, 106437].

Juan M Godoy-Corchuelo, Zeinab Ali, Jose M Brito Armas, Aurea B Martins-Bach, Irene García-Toledo, Luis C Fernandez-Beltrán, Juan I Lopez-Carbonero, Pablo Bascunana, Shoshana Spring, Irene Jimenez-Coca and 11 more

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Neurobiology of disease, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

21 authors.

Juan M Godoy-CorchueloNeurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain.
Zeinab AliNeurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain; MRC Harwell Institute, Oxfordshire, UK.
Jose M Brito ArmasUnidad de Investigación, Hospital Universitario de Canarias, ITB-ULL and CIBERNED, La Laguna, Spain.
Aurea B Martins-BachWellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.
Irene García-ToledoNeurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain.
Luis C Fernandez-BeltránNeurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain; Department of Medicine, Universidad Complutense de Madrid, Madrid, Spain.
Juan I Lopez-CarboneroNeurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain.
Pablo BascunanaBrain Mapping Group, Hospital Clínico San Carlos, IdISSC, Madrid, Spain.
Shoshana SpringMouse Imaging Centre, The Hospital for Sick Children, Toronto, ON, Canada.
Irene Jimenez-CocaNeurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain.
Ramón A Muñozde Bustillo AlfaroUnidad de Investigación, Hospital Universitario de Canarias, ITB-ULL and CIBERNED, La Laguna, Spain.
Maria J Sanchez-BarrenaDepartment of Crystallography and Structural Biology, Institute of Physical Chemistry "Blas Cabrera", CSIC, Madrid, Spain.
Remya R NairMRC Harwell Institute, Oxfordshire, UK; Nucleic Acid Therapy Accelerator (NATA), Harwell Campus, Oxfordshire, UK.
Brian J NiemanMouse Imaging Centre, The Hospital for Sick Children, Toronto, ON, Canada.
Jason P LerchWellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.
Karla L MillerWellcome Centre for Integrative Neuroimaging, University of Oxford, Oxford, UK.
Hande P OzdinlerDepartment of Neurology, Feinberg School of Medicine, Northwestern University, Chicago, IL, USA.
Elizabeth M C FisherDepartment of Neuromuscular Diseases, UCL Queen Square Motor Neuron Disease Centre, UCL, Institute of Neurology, London, UK.
Thomas J CunninghamMRC Harwell Institute, Oxfordshire, UK; MRC Prion Unit at UCL, UCL Institute of Prion Diseases, London, UK.
Abraham Acevedo-ArozenaUnidad de Investigación, Hospital Universitario de Canarias, ITB-ULL and CIBERNED, La Laguna, Spain.
Silvia CorrochanoNeurological Disorders Group, Hospital Clínico San Carlos, Instituto de Investigación Sanitaria Hospital Clínico San Carlos (IdiSSC), Madrid 28040, Spain; MRC Harwell Institute, Oxfordshire, UK. Electronic address: silvia.corrochano@salud.madrid.org.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID39462744
PMCPMC11614576

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.